Effects of Atomoxetine in Mild Cognitive Impairment
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Mild Cognitive Impairment
Related studies linked through entity extraction aliases.
Mild Cognitive Impairment in Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Evaluation of Florbetapir F 18 (18F-AV-45)
- Status
- COMPLETED
- Phase
- PHASE2
The Montreal Cognitive Assessment as a Screening Tool for Preoperative Mild Cognitive Impairment in Geriatric Patients
- Status
- UNKNOWN
- Phase
- N/A
Cognitive Assessment of Elderly Primary Care Patients
- Status
- COMPLETED
- Phase
- NA
Mild Cognitive Impairment and Obstructive Sleep Apnea
- Status
- COMPLETED
- Phase
- NA
Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease
- Status
- TERMINATED
- Phase
- PHASE1
Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer Type
- Status
- UNKNOWN
- Phase
- N/A
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
- Status
- COMPLETED
- Phase
- N/A
Efficiency of Deep Transcranial Magnetic Stimulation on Patients With Mild Cognitive Impairment
- Status
- UNKNOWN
- Phase
- PHASE1
Minocycline in Patients With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
DaTSCAN Imaging in Aging and Neurodegenerative Disease
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE4
Efficacy and Safety Study of Shenwu Capsule
- Status
- COMPLETED
- Phase
- PHASE3
Measuring the Impact of Cognitive and Psychosocial Interventions in Persons With Mild Cognitive Impairment
- Status
- COMPLETED
- Phase
- NA
Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to Dementia
- Status
- UNKNOWN
- Phase
- N/A
Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV
- Status
- COMPLETED
- Phase
- NA
A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment
- Status
- COMPLETED
- Phase
- PHASE2
Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment
- Status
- COMPLETED
- Phase
- NA
Alzheimer's Disease Core Center
- Status
- UNKNOWN
- Phase
- N/A
NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)
- Status
- COMPLETED
- Phase
- N/A